ERYTECH
ERYtech Pharma specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.
ERYTECH
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
Lyon, Rhone-Alpes, France
Country:
France
Website Url:
http://www.erytech.com
Total Employee:
101+
Status:
Active
Contact:
33(0)4-78-74-44-38
Total Funding:
227.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Armistice Capital
Armistice Capital investment in Post-IPO Equity - erytech
Bpifrance
Bpifrance investment in Post-IPO Debt - erytech
Societe Generale
Societe Generale investment in Post-IPO Debt - erytech
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - erytech
Andera Partners
Andera Partners investment in Post-IPO Equity - erytech
Auriga Partners
Auriga Partners investment in Series D - erytech
Auriga Partners
Auriga Partners investment in Series C - erytech
Auriga Partners
Auriga Partners investment in Series B - erytech
Ardian
Ardian investment in Venture Round - erytech
Auriga Partners
Auriga Partners investment in Venture Round - erytech
Official Site Inspections
http://www.erytech.com
- Host name: plesk-adv2.theraconseil.com
- IP address: 178.33.144.180
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "erytech"
erytech - Crunchbase Company Profile & Funding
ERYtech Pharma specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy …See details»
Erytech Pharma - Overview, News & Similar companies - ZoomInfo
Who is Erytech Pharma. ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. …See details»
ERYTECH Provides Business and Financial Update for the First …
May 9, 2023 Lyon (France) and Cambridge (MA, US), May 9, 2023 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing …See details»
Erytech Pharma Company Profile - Craft
Aug 29, 2023 Erytech is a biopharmaceutical company developing innovative therapies to target unmet medical needs, particularly in the fields of cancer and orphan diseases. Erytech’s …See details»
ERYTECH Provides Business and Financial Update for the First …
May 9, 2023 ERYTECH Provides Business and Financial Update for the First Quarter of 2023 Combination with Pherecydes, intending to create a global leader in extended phage therapies …See details»
ERYTECH Provides Business and Financial Update for the Fourth …
Mar 22, 2023 ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022 Combination with Pherecydes announced, intending to create a global leader …See details»
ERYTECH Provides Update on the Announced Combination with …
May 15, 2023 As announced in ERYTECH’s press release of February 15, 2023, ERYTECH’s board of directors approved on May 5, 2023, the contribution by Elaia Partners, Go Capital …See details»
ERYTECH Announces Filing of 2021 Universal Registration …
Apr 28, 2022 Cambridge, MA (U.S.) and Lyon (France), April 28, 2022 – ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company …See details»
ERYTECH Provides Business and Financial Update for the Third …
Nov 21, 2022 Cambridge, MA (U.S.) and Lyon (France), November 21, 2022 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing …See details»
ERYTECH Sells U.S. Manufacturing Facility and Enters
Apr 25, 2022 ERYTECH Eric Soyer CFO & COO: NewCap Mathilde Bohin / Louis-Victor Delouvrier Investor relations Nicolas Merigeau Media relations +33 4 78 74 44 38 …See details»
ERYTECH Provides Business and Financial Update for the First Half …
Sep 12, 2022 Erytech PharmaSA 60 Avenue Rockefeller 69008 Lyon France. Erytech Pharma Inc. 1 Main Street, Suite 300 Cambridge, MA 02142 USASee details»
ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term …
Apr 25, 2022 ERYTECH is evaluating valuable strategic options to leverage its ERYCAPS® platform and its development and manufacturing capabilities with complementary assets …See details»
ERYTECH Provides Update on the Announced Combination with
May 15, 2023 As announced in ERYTECH’s press release of February 15, 2023, ERYTECH’s board of directors approved on May 5, 2023, the contribution by Elaia Partners, Go Capital …See details»
ERYTECH Announces $7.85 Million Registered Direct Offering
Dec 14, 2021 ERYTECH disclaims any obligation to update any such forward-looking statement, forecast or estimates to reflect any change in ERYTECH’s expectations with regard thereto, or …See details»
ERYTECH and PHERECYDES announce merger and name change …
Jun 26, 2023 The company will furthermore leverage ERYTECH’s US presence to facilitate access to US investors and to clinical and regulatory stakeholders in the perspective of …See details»
ERYTECH Provides Business and Financial Update for the Third …
Nov 21, 2022 ERYTECH Provides Business and Financial Update for the Third Quarter of 2022 Conference call and webcast on Tuesday, November 22, 2022at 8:30am ET / 02:30pm CET …See details»
ERYTECH Provides Regulatory Update
[email protected] +33 1 44 71 94 94 [email protected] Forward-looking information This press release contains forward-looking statements, forecasts and estimates with respect to the …See details»
ERYTECH Highlights 2021 Milestones and Provides Update on
Jan 25, 2021 Lyon (France) and Cambridge, MA (U.S.), January 25, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing …See details»
ERYTECH and PHERECYDES Announce Proposed Combination …
ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies Conference call and webcast in English on February 16, …See details»
ERYTECH Provides Regulatory Update | Phaxiam Therapeutics
Aug 24, 2022 Following positive results of a Phase 2 trial, sponsored by the Nordic Organization for Paediatric Haematology and Oncology (NOPHO), presented at the 2020 American Society …See details»